Role of matrix metalloproteinase‑7 and apoptosis‑associated gene expression levels in the pathogenesis of atrial fibrosis in a Beagle dog model

Jia,Min; Li,Zai‑Bo; Li,Lin; Chu,Hong‑Tao; Li,Zhuang‑Zhuang

doi:10.3892/mmr.2017.7415

Role of matrix metalloproteinase‑7 and apoptosis‑associated gene expression levels in the pathogenesis of atrial fibrosis in a Beagle dog model

Authors:
- Min Jia
- Zai‑Bo Li
- Lin Li
- Hong‑Tao Chu
- Zhuang‑Zhuang Li
View Affiliations

Affiliations: Department of Cardiology, Zaozhuang Municipal Hospital, Zaozhuang, Shandong 277102, P.R. China, Department of Cardiology, Shizhong People's Hospital of Zaozhuang, Zaozhuang, Shandong 277102, P.R. China
Published online on: August 31, 2017 https://doi.org/10.3892/mmr.2017.7415
Pages: 6967-6973

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the potential role of matrix metalloproteinase‑7 (MMP‑7) and apoptosis‑associated genes [TIMP metallopeptidase inhibitor 2(TIMP‑2), BCL2 associated X, apoptosis regulator (BAX) and BCL2, apoptosis regulator (BCL‑2)] in the pathogenesis of atrial fibrillation (AF) in a Beagle dog model. A total of 20 adult male Beagle dogs were randomly assigned into the AF group (n=10; Beagle dogs were treated by Burst stimulation to induce AF) and the control group (n=10; healthy Beagle dogs). Echocardiography and Mallory staining were used to determine cardiac function and degree of atrial fibrosis, respectively. Reverse transcription‑quantitative polymerase chain reaction and western blotting were performed to determine collagen type 1 (Col I), MMP‑7, TIMP‑2, BAX and BCL‑2 mRNA and protein expression levels. Compared with the control group, the AF group presented increased degree of atrial fibrosis and level of Col I expression, elevated MMP‑7 and BAX expression levels, but decreased TIMP‑2 and BCL‑2 expression levels. Correlation analysis demonstrated that MMP‑7 and BAX protein expression levels were negatively correlated with left ventricular ejection fraction (LVEF), but positively correlated with the degree of atrial fibrosis. Negative correlation was observed between TIMP‑2 and BCL‑2 protein expression levels and degree of atrial fibrosis. In addition, a positive correlation between TIMP‑2 and BCL‑2 protein expression levels and LEVF was observed. These results demonstrate that MMP‑7 and BAX were highly expressed, while TIMP‑2 and BCL‑2 were downregulated in a Beagle dog model of AF, indicating that MMP‑7 and apoptosis‑associated genes (TIMP‑2, BAX and BCL‑2) may be associated with the pathogenesis of AF.

View Figures

View References

1	Gu J, Hu W and Liu X: The value of magnetic resonance imaging in catheter ablation of atrial fibrillation. Clin Cardiol. 38:190–194. 2015. View Article : Google Scholar : PubMed/NCBI
2	Gandolfo C, Balestrino M, Bruno C, Finocchi C and Reale N: Validation of a simple method for atrial fibrillation screening in patients with stroke. Neurol Sci. 36:1675–1678. 2015. View Article : Google Scholar : PubMed/NCBI
3	Carpi A, Cini G, Russo M, Antonelli A, Gaudio C, Galetta F, Franzoni F and Rossi G: Subclinical hyperthyroidism and cardiovascular manifestations: A reevaluation of the association. Intern Emerg Med. 8 Suppl 1:S75–S77. 2013. View Article : Google Scholar : PubMed/NCBI
4	Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, et al: Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF study. JAMA. 311:498–506. 2014. View Article : Google Scholar : PubMed/NCBI
5	Mukherjee R, Akar JG, Wharton JM, Adams DK, McClure CD, Stroud RE, Rice AD, DeSantis SM, Spinale FG and Gold MR: Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion. J Cardiovasc Transl Res. 6:528–535. 2013. View Article : Google Scholar : PubMed/NCBI
6	Wang Y, Zhang H, Chai F, Liu X and Berk M: The effects of escitalopram on myocardial apoptosis and the expression of Bax and Bcl-2 during myocardial ischemia/reperfusion in a model of rats with depression. BMC Psychiatry. 14:3492014. View Article : Google Scholar : PubMed/NCBI
7	Papazafiropoulou A and Tentolouris N: Matrix metalloproteinases and cardiovascular diseases. Hippokratia. 13:76–82. 2009.PubMed/NCBI
8	Loreto C, Leonardi R, Musumeci G, Pannone G and Castorina S: An ex vivo study on immunohistochemical localization of MMP-7 and MMP-9 in temporomandibular joint discs with internal derangement. Eur J Histochem. 57:e122013. View Article : Google Scholar : PubMed/NCBI
9	O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M and Kay E: Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: Implications for tumour progression. Histopathology. 51:793–804. 2007. View Article : Google Scholar : PubMed/NCBI
10	Chen CL, Huang SK, Lin JL, Lai LP, Lai SC, Liu CW, Chen WC, Wen CH and Lin CS: Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation. J Mol Cell Cardiol. 45:742–753. 2008. View Article : Google Scholar : PubMed/NCBI
11	Barclay LA, Wales TE, Garner TP, Wachter F, Lee S, Guerra RM, Stewart ML, Braun CR, Bird GH, Gavathiotis E, et al: Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. Mol Cell. 57:873–886. 2015. View Article : Google Scholar : PubMed/NCBI
12	Lewkowicz J, Knapp M, Tankiewicz-Kwedlo A, Sawicki R, Kamińska M, Waszkiewicz E and Musiał WJ: MMP-9 in atrial remodeling in patients with atrial fibrillation. Ann Cardiol Angeiol (Paris). 64:285–291. 2015. View Article : Google Scholar : PubMed/NCBI
13	Xu GJ, Gan TY, Tang BP, Chen ZH, Mahemuti A, Jiang T, Song JG, Guo X, Li YD, Miao HJ, et al: Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences. Exp Ther Med. 5:723–729. 2013. View Article : Google Scholar : PubMed/NCBI
14	Myers RP, Patel K, Pianko S, Poynard T and McHutchison JG: The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C. J Viral Hepat. 10:16–22. 2003. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Tesfaigzi Y, Myers OB, Stidley CA, Schwalm K, Picchi M, Crowell RE, Gilliland FD and Belinsky SA: Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chron Obstruct Pulmon Dis. 1:267–278. 2006.PubMed/NCBI
17	Wang W, Zhang HT and Yang XL: Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling. J Cardiovasc Med (Hagerstown). 14:265–269. 2013. View Article : Google Scholar : PubMed/NCBI
18	Kalogeropoulos AS, Tsiodras S, Rigopoulos AG, Sakadakis EA, Triantafyllis A, Kremastinos DT and Rizos I: Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation. BMC Cardiovasc Disord. 11:772011. View Article : Google Scholar : PubMed/NCBI
19	Takawale A, Sakamuri SS and Kassiri Z: Extracellular matrix communication and turnover in cardiac physiology and pathology. Compr Physiol. 5:687–719. 2015. View Article : Google Scholar : PubMed/NCBI
20	Spinale FG: Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev. 87:1285–1342. 2007. View Article : Google Scholar : PubMed/NCBI
21	Camelliti P, Borg TK and Kohl P: Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res. 65:40–51. 2005. View Article : Google Scholar : PubMed/NCBI
22	Vanhoutte D, Schellings M, Pinto Y and Heymans S: Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window. Cardiovasc Res. 69:604–613. 2006. View Article : Google Scholar : PubMed/NCBI
23	Saxena A, Chen W, Su Y, Rai V, Uche OU, Li N and Frangogiannis NG: IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol. 191:4838–4848. 2013. View Article : Google Scholar : PubMed/NCBI
24	Kvansakul M and Hinds MG: The Bcl-2 family: Structures, interactions and targets for drug discovery. Apoptosis. 20:136–150. 2015. View Article : Google Scholar : PubMed/NCBI
25	Hoshyar R, Bathaie SZ and Sadeghizadeh M: Crocin triggers the apoptosis through increasing the Bax/Bcl-2 ratio and caspase activation in human gastric adenocarcinoma, AGS, cells. DNA Cell Biol. 32:50–57. 2013. View Article : Google Scholar : PubMed/NCBI
26	Diao SL, Xu HP, Zhang B, Ma BX and Liu XL: Associations of MMP-2, BAX, and BCL-2 mRNA and protein expressions with development of atrial fibrillation. Med Sci Monit. 22:1497–1507. 2016. View Article : Google Scholar : PubMed/NCBI